Most of the confusion around HGH comes from two claims that sound like they contradict each other. One says growth hormone burns fat. The other says it builds. Both are true, and they are not in conflict, because they describe the same hormone doing two different jobs under two different conditions. The condition that flips it from one job to the other is insulin, the hormone your body releases when you eat.

This article walks through the full timeline of exogenous HGH, which just means growth hormone you inject rather than the kind your body makes on its own. It covers what happens the moment it goes in, why the fat burning window has a delayed start and a hard ceiling, what building actually refers to at the tissue level, how long the effect outlasts the hormone itself, and the one wrinkle that quietly catches researchers who are running retatrutide at the same time.

Growth hormone does not carry out a single fixed task. Over the hours it is active, what it does is decided almost entirely by one thing, which is where your insulin is sitting. Insulin is the hormone your body releases in response to food, and part of its job is to store energy and shut down fat release.

When growth hormone is active and insulin is low, the balance leans toward releasing stored fat. When growth hormone is active and insulin is high, the fat side is muted and the balance tips toward building and repair instead. Same hormone, same dose, opposite direction. That is the whole reason timing matters as much as it does.

Injected subq, which means just into the layer of fat below the skin, growth hormone does not spike immediately. Research on injected growth hormone suggests the level in your blood climbs over a few hours before it peaks. So the effect is delayed. It is not strongest the moment the needle comes out, and it is not gone a few minutes later.

Across those active hours, what the hormone does splits into two paths. One path runs when insulin is low. The other runs when insulin is high. Everything below follows from which of those two states you are in while the hormone is working.

When insulin is low, growth hormone leans toward lipolysis, which is just the releasing of stored fat. It breaks down stored fat, called triglycerides, so the body can use it for energy. Based on the data, this does not happen as a quick burst that then stops. It comes on with the same delay as the hormone itself, then runs for a stretch of hours while insulin stays down.

So the honest answer to how long fat burning lasts is that in the low insulin state it is a delayed and then sustained effect that runs across the active life of the hormone. It is not a short window right after you inject. It also has a ceiling. The moment you eat, insulin rises and the fat release gets shut off. The window closes not on a timer but on your next meal.

How much fat gets released in that window is not fixed either. It tracks with how high growth hormone climbs in the blood, what researchers call pulse height. A higher peak sends a stronger release signal to more fat cells at once. This is why the state you inject into matters so much. A strong peak that lands in a low insulin window does real work. The same peak landing in a fed window is mostly wasted on the fat side.

Now take the fed state. Say you ate not long before. Insulin works against fat release directly, on its own, regardless of the growth hormone sitting there. So when insulin is up, the fat side of the hormone is muted and the balance tips toward the building side.

That building side does not run through growth hormone doing the work itself. Growth hormone mostly tells your liver to make a second hormone called IGF-1, which stands for insulin-like growth factor 1. IGF-1 is the messenger that actually carries out much of what people credit growth hormone for, including recovery, tissue repair, and holding onto muscle. The liver makes IGF-1 in proportion to the growth hormone signal it receives, so a stronger pulse produces more of it.

Here is the part worth being precise about. When building is the word being used, based on the research it is closer to protecting and holding onto the muscle you already have than to adding brand new muscle out of nothing. So high insulin and high growth hormone at the same time still does something useful. It just steers the hormone toward repair and preservation and away from the fat burning side, which is usually the side most people were after.

Injected growth hormone has what is called a half-life, which is just the time it takes for half of the dose to clear out of your blood. Based on research, for injected growth hormone that is a matter of a few hours. So within several hours the hormone itself is largely gone from your bloodstream.

But the hormone clearing out is not the same as its effects clearing out. IGF-1, that downstream messenger, hangs around considerably longer than the growth hormone molecule that triggered it, in part because it travels bound to carrier proteins that slow how fast it clears. So there is a real stretch where the growth hormone you injected is basically gone while the work it set in motion through IGF-1 is still going. This is why the question of when it is fully out of your system has two answers. The hormone is a matter of hours. The effect it kicked off runs longer.

One accuracy point so the direction does not get reversed. When your insulin falls after a meal, that is the meal clearing on its own schedule. It is not the growth hormone bringing your insulin down. If anything, growth hormone works against insulin. Researchers call it counter-regulatory, and over its active window it tends to nudge insulin and blood sugar up, not down.

This matters for two reasons. First, it is why the state you are in when you inject is so important, because the hormone is not going to pull a high insulin state down for you and open the fat window on its own. Second, it is why extended or higher dose growth hormone use is associated with insulin resistance over time. The same counter-regulatory effect that makes timing matter in the short term is the effect that can move your fasting glucose in the wrong direction across a long protocol.

There is one wrinkle for anyone researching this while running retatrutide, and it is easy to miss because it works by feel rather than by the clock. Retatrutide is an investigational compound that acts on three receptors at once. It is a GLP-1, GIP, and glucagon receptor agonist, which in plain terms means it works the satiety and insulin pathway, a second incretin pathway that handles nutrient signaling, and the glucagon pathway that tells the body to draw on stored energy.

Two of retatrutide's effects change the insulin picture that everything above depends on. The first is that it slows gastric emptying, which is how fast food leaves your stomach. Food sits longer, nutrients absorb over a longer window, and insulin stays elevated for longer after a meal than it would off the compound. The second is that it blunts appetite and quiets food noise. That is useful for intake, but it means not feeling full is no longer a reliable sign that you are back in a low insulin state.

Put those together and the problem becomes clear. On retatrutide you can feel empty and assume you are in the fasted, fat releasing window, while your insulin is actually still elevated from a meal several hours earlier. Growth hormone injected into that moment lands in the high insulin path, the building and preservation side, instead of the fat release side you were aiming for. Off retatrutide, hunger tracks your insulin state reasonably well. On it, that link is broken, which is why timing on the compound has to lean on when you actually ate rather than on how hungry you feel.

This content is for educational and research purposes only. It is not medical advice, and it does not recommend or instruct the use of any compound. Speak with a qualified medical provider before making any decision related to your health.